The Spinal Cord Stimulators Market has grown significantly in recent years, owing to the increasing prevalence of chronic pain conditions and the growing demand for non-pharmacological pain management solutions. Spinal cord stimulators (SCS) are medical devices that deliver electrical impulses to the spinal cord, thereby blocking pain signals and providing relief to patients suffering from conditions such as failed back surgery syndrome, complex regional pain syndrome, and neuropathic pain.
The global spinal cord stimulators market was worth US$ 2.4 billion at the end of 2021 and is expected to grow at a CAGR of 7.5% from 2022 to 2032. With a market share of 67.3% in 2021, the rechargeable stimulator product leads the spinal cord stimulators market.
Unleash Your Potential with Precision and Performance! Claim Your Complimentary Sample Today and Experience the Power of Unmatched Efficiency:
https://www.futuremarketinsights.com/reports/sample/rep-gb-2030
Spinal cord stimulation is one of the most effective methods for managing chronic pain. The rising prevalence of chronic pain and the cost-effectiveness of spinal cord stimulators, as well as better reimbursement policies, companies’ emphasis on product promotion, and the effectiveness of spinal cord stimulators in reducing opioid analgesic use, are expected to drive the spinal cord stimulators market.
Spinal cord stimulation is considered one of the most effective methods to cure chronic pain management. Owing to the rising prevalence of chronic pain and cost-effectiveness of spinal cord stimulators, better reimbursement policies, companies’ focus on promoting their product, and the effectiveness of spinal cord stimulators in reduction of opioid analgesics use are expected to boost the spinal cord stimulators market.
Key Takeaways
- The growth of the spinal cord stimulation market is expected to be driven by regular enhancements in technologies, the broad availability of healthcare facilities, and non-invasive treatments/surgeries. The government’s initiatives and policies are also acting in the favor of the market.
- Meticulous research and development enable manufacturers to cope with the growing demand and utilize newer technologies in the market. Various treatments like stem cell therapy and functional electrical stimulation (FES) have shown promising results in paralyzed patients. FES treatment utilizes a computer and electrodes in order to give small electronic bursts to paralyzed muscles for their stimulation and movement.
- According to the studies, the most utilized therapy is known as “HF10” which is proven to be a successful treatment in spinal cord stimulation. This technology is deployed for conditions typically treated with spinal cord stimulators (SCS), especially chronic low back and leg pain. Owing to its effective and instant relief, this type of treatment is gaining traction rapidly.
- In addition to that, there is a significant rise in awareness among physicians & patients and the introduction of technologically advanced devices is the major factor driving the growth of the spinal cord stimulators market.
- Failed back surgery syndrome is efficiently treated by spinal cord stimulators, complex regional pain syndrome, and ischemic limb pain. Spinal cord stimulation therapy is designed in such a way that delivers low-voltage electrical pulses to stimulate the spinal cord nerve fibers that are involved in the body’s neural pain signal pathway. By stimulating these nerves, the delivery of pain messages to the brain is interrupted, therefore, providing the patient with a diminished sensation of pain.
Key Players:
- Medtronic Public Limited Company,
- Boston Scientific Corp,
- St Jude Medical LLC and Nevro Corp,
- Nuvectra Corporation and Stimwave,
- Neurosigma Inc.,
- Synapse Biomedical Inc.,
- Abbott Laboratories,
- Beijing PINS Medical Co., Ltd,
- Cirtec Medical Corporation,
- Gimer Medical,
- Bluewind Medical,
- Bioinduction,
- Greatbatch, Inc.,
- Saluda Medical Pty Ltd.
Uncover hidden opportunities with our proven methodology:
https://www.futuremarketinsights.com/request-report-methodology/rep-gb-2030
More Insights into the Spinal Cord Stimulators Market
The U.S. is expected to dominate the global spinal cord stimulators market over the forecast period as it accounted for about US$ 1.8 Bn in 2021. The dominance of the North American region is expected due to favorable schemes and policies provided by the government and technological advancements in the healthcare sector.
Germany is the second leading market which accounted for US$ 56.0 Mn in 2021. Increased healthcare funding by organizations and insurances on medical care & nurse care is one of the significant factors improving the growth in the market.
Japan is expected to witness phenomenal growth over the assessment period as it possessed about US$ 117.9 Mn revenue in 2021 and is anticipated to surge at a CAGR of 7.1% surpassing US$ 246.9 Mn by 2032. Growth is due to the rising number of patients experiencing neuropathic pain and opting for spinal procedures as a result of trauma and injuries.
Spinal Cord Stimulators Segments:
Products:
- Rechargeable
- Non-Rechargeable
Application:
- Failed back Surgery Syndrome
- Complex Regional Pain Syndrome
- Ischemic Limb pain
- Others
End User:
- Hospitals
- Ambulatory Surgical Centers
- Clinics
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube